These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 24113395
1. Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. Amornkul PN, Karita E, Kamali A, Rida WN, Sanders EJ, Lakhi S, Price MA, Kilembe W, Cormier E, Anzala O, Latka MH, Bekker LG, Allen SA, Gilmour J, Fast PE, IAVI Africa HIV Prevention Partnership. AIDS; 2013 Nov 13; 27(17):2775-86. PubMed ID: 24113395 [Abstract] [Full Text] [Related]
2. Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study. Ssemwanga D, Nsubuga RN, Mayanja BN, Lyagoba F, Magambo B, Yirrell D, Van der Paal L, Grosskurth H, Kaleebu P. PLoS One; 2013 Nov 13; 8(8):e71768. PubMed ID: 23951241 [Abstract] [Full Text] [Related]
3. Rapid disease progression in HIV-1 subtype C-infected South African women. Mlisana K, Werner L, Garrett NJ, McKinnon LR, van Loggerenberg F, Passmore JA, Gray CM, Morris L, Williamson C, Abdool Karim SS, Centre for the AIDS Programme of Research in South Africa (CAPRISA) 002 Study Team. Clin Infect Dis; 2014 Nov 01; 59(9):1322-31. PubMed ID: 25038116 [Abstract] [Full Text] [Related]
4. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Geretti AM, Harrison L, Green H, Sabin C, Hill T, Fearnhill E, Pillay D, Dunn D, UK Collaborative Group on HIV Drug Resistance. Clin Infect Dis; 2009 May 01; 48(9):1296-305. PubMed ID: 19331585 [Abstract] [Full Text] [Related]
5. Short Communication: The Interaction of HIV Set Point Viral Load and Subtype on Disease Progression. McPhee E, Grabowski MK, Gray RH, Ndyanabo A, Ssekasanvu J, Kigozi G, Makumbi F, Serwadda D, Quinn TC, Laeyendecker O. AIDS Res Hum Retroviruses; 2019 Jan 01; 35(1):49-51. PubMed ID: 30520309 [Abstract] [Full Text] [Related]
6. Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries. Wall KM, Rida W, Haddad LB, Kamali A, Karita E, Lakhi S, Kilembe W, Allen S, Inambao M, Yang AH, Latka MH, Anzala O, Sanders EJ, Bekker LG, Edward VA, Price MA. Epidemiology; 2017 Mar 01; 28(2):224-232. PubMed ID: 27893488 [Abstract] [Full Text] [Related]
7. Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts. Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K, CASCADE collaboration in EuroCoord. Clin Infect Dis; 2013 Mar 01; 56(6):888-97. PubMed ID: 23223594 [Abstract] [Full Text] [Related]
8. HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels. Eller MA, Opollo MS, Liu M, Redd AD, Eller LA, Kityo C, Kayiwa J, Laeyendecker O, Wawer MJ, Milazzo M, Kiwanuka N, Gray RH, Serwadda D, Sewankambo NK, Quinn TC, Michael NL, Wabwire-Mangen F, Sandberg JK, Robb ML. J Infect Dis; 2015 May 15; 211(10):1574-84. PubMed ID: 25404522 [Abstract] [Full Text] [Related]
9. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KC, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TF, PharmAccess African Studies to Evaluate Resistance (PASER). Lancet Infect Dis; 2011 Oct 15; 11(10):750-9. PubMed ID: 21802367 [Abstract] [Full Text] [Related]
10. Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa. Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, Rwambuya S, Munjoma M, Chipato T, Byamugisha J, Van Der Pol B, Mugyenyi P, Salata RA, Morrison CS, Arts EJ. EBioMedicine; 2016 Nov 15; 13():305-314. PubMed ID: 27751765 [Abstract] [Full Text] [Related]
11. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E, MOBIDIP study group. Lancet HIV; 2017 Sep 15; 4(9):e384-e392. PubMed ID: 28566227 [Abstract] [Full Text] [Related]
12. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, Rutebemberwa A, Lyagoba F, Hamilton L, Biryahwaho B, Whitworth J. AIDS; 2001 Feb 16; 15(3):293-9. PubMed ID: 11273208 [Abstract] [Full Text] [Related]
13. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Haas AD, Keiser O, Balestre E, Brown S, Bissagnene E, Chimbetete C, Dabis F, Davies MA, Hoffmann CJ, Oyaro P, Parkes-Ratanshi R, Reynolds SJ, Sikazwe I, Wools-Kaloustian K, Zannou DM, Wandeler G, Egger M, IeDEA southern Africa, east Africa, and west Africa. Lancet HIV; 2015 Jul 16; 2(7):e271-8. PubMed ID: 26423252 [Abstract] [Full Text] [Related]
14. Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. Keller M, Lu Y, Lalonde RG, Klein MB. AIDS; 2009 Mar 27; 23(6):731-7. PubMed ID: 19279446 [Abstract] [Full Text] [Related]
15. Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. Gray CM, Williamson C, Bredell H, Puren A, Xia X, Filter R, Zijenah L, Cao H, Morris L, Vardas E, Colvin M, Gray G, McIntyre J, Musonda R, Allen S, Katzenstein D, Mbizo M, Kumwenda N, Taha T, Karim SA, Flores J, Sheppard HW. AIDS Res Hum Retroviruses; 2005 Apr 27; 21(4):285-91. PubMed ID: 15943570 [Abstract] [Full Text] [Related]
16. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, Mulenga J, Kasolo F, Vermund SH, Aldrovandi GM. AIDS Res Hum Retroviruses; 2001 Jul 01; 17(10):901-10. PubMed ID: 11461676 [Abstract] [Full Text] [Related]
17. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. Staehelin C, Rickenbach M, Low N, Egger M, Ledergerber B, Hirschel B, D'Acremont V, Battegay M, Wagels T, Bernasconi E, Kopp C, Furrer H, Swiss HIV Cohort Study. AIDS; 2003 Oct 17; 17(15):2237-44. PubMed ID: 14523281 [Abstract] [Full Text] [Related]
18. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. N Engl J Med; 2001 Mar 08; 344(10):720-5. PubMed ID: 11236775 [Abstract] [Full Text] [Related]
19. Disease progression and survival in HIV-1-infected Africans in London. Del Amo J, Petruckevitch A, Phillips A, Johnson AM, Stephenson J, Desmond N, Hanscheid T, Low N, Newell A, Obasi A, Paine K, Pym A, Theodore CM, De Cock KM. AIDS; 1998 Jul 09; 12(10):1203-9. PubMed ID: 9677170 [Abstract] [Full Text] [Related]
20. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa. Boender TS, Hoenderboom BM, Sigaloff KC, Hamers RL, Wellington M, Shamu T, Siwale M, Labib Maksimos EE, Nankya I, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Ondoa P, Rinke de Wit TF. Clin Infect Dis; 2015 Dec 01; 61(11):1749-58. PubMed ID: 26240203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]